Special situation · 224 dossiers

The 2026-08-04 bounce failed: ARCB lost the $136 shelf on a 2026-08-06 close of $135.25 and printed a post-print low of $134.75 on 08-07, while three open-market director sales — the first of 2026 — executed at $138.71–$144.85 on 08-04 and…

Record made 2026-08-04 ($190.46 close, $195.70 intraday) has held — 2026-08-07 closed $189.52 with no give-back. Second tuck-in in three weeks (JetStream, 2026-08-06, undisclosed). No Q1 FY27 webcast notice as of 2026-08-09, which argues…

Atera's order book turned the name: the 2026-08-06 beat-and-raise first sold to $45.60, then reversed to a record $52.03 close on 2026-08-07 (+14.10%, 5.43M shares) with the 16-analyst average target moving $41.54→$46.31 in two sessions.…

Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2…

BTC→AI landlord whose operating build (>1 GW contracted, ~$31B backlog, 175 MW live) has decoupled from an equity that halved from $49.65 to a $25.79 low, now bouncing off the $25.56 April base into a binary FY26 print on 2026-07-27.…

Neocloud re-rate has fully round-tripped: $33.62 close 7/17, -42% in 30 days, late-May Microsoft breakout base surrendered. Contracts intact ($9.7B MSFT, prepaid tranches) but Q3 AI revenue was only $17.3M vs a $3.4B ARR ambition, and…

Legacy crypto-financials name re-rating to AI-data-center landlord: Phase I ~200MW at the Helios campus was delivered to CoreWeave on 2026-07-06, turning the ~$4.5B/15-yr lease from promise into live contracted revenue while shares still…

Bitcoin-miner-to-AI-datacenter-landlord re-rate is now financed fact ($4.25B IG notes 6/4, ~$16.8B contracted backlog), but the momentum leg rolled from ~$127 to ~$105 as peers WULF/IREN captured the marquee Anthropic tenant deals (7/6)…

Post-liquidation base holding but not extending: four closes $99.81–$101.65 (2026-08-04 to 08-07) while volume decayed ~40% from the reversal day. Terafab's Grimes County site confirmation and SoftBank's $8.2B Intel gain add narrative…

The data-center re-rating already failed: QCOM spiked to a 52-week high of $259.92 on the ~2026-06-24 Investor Day $15B-by-2029 guide, then gave back ~34% in 17 sessions to $171.78 as Hold downgrades and Apple modem-attrition math…

BTC-to-AI-landlord re-rating is structurally intact — AMD $311M/50MW Rockdale lease, $33.2M Q1 data-center revenue, Citi reiterated Buy/PT $28 on 2026-07-08 — but the miner complex rolled over on a Q2 crypto rout and "fresh AI-pivot…

Conway extract/RTD/flavors platform inflecting capex-to-cash: Q1 (5/07) beat + record adj EBITDA + FCF-positive-H2 guide; the 6/30 debt-maturity extension cleared the refi wall. Stock re-rated to ~$9.50 near the $9.81 52-wk high. Q2…

Life-settlements franchise bolted the RWA-tokenization narrative (100+ policies on-chain, $224B TAM) onto a Q1 beat and a raised FY adj-EPS guide, but shares rejected the $12.44 high with a −7.3% sell-the-news day into a binary ~2026-08-06…

Post-crash re-rating leg: the 2026-06-18 FY26 guide cut took ACN -17.9% in a day to a $118.15 low, then a $7.5B buyback (+62% YoY, must complete by 2026-08-31) plus named AI wins (Google Cloud, NATO, UniCredit) drove +24.8% in four…

Record-revenue franchise priced for terminal AI disruption: closed 2026-07-31 at $250.41, ~9.6x NTM earnings vs Microsoft 23.1x, 31% below the 52-week high, with a $25B buyback running. The bear narrative is fully mainstream and nothing…

De-rated design-software compounder: Q1 FY27 revenue +18% to $1.934B and current RPO +18%, against a stock 23.8% under its $326.79 high. The $3.6B MaintainX close (2026-08-03) extends the franchise from CAD seats into asset operations; the…

The ADVA-merger margin-recovery turnaround — the whole reason for the ~$7→$20 re-rate — cracked on the 2026-07-22 preliminary Q2 miss (rev $280–282M below guide, non-GAAP operating margin ~3.5–4% vs a 5–9% target, GAAP loss, EPS collapsing…

Frac-sand legacy pivoting to behind-the-meter gas power for AI data centers, but the story is DORMANT and the structure broken: shares fell from $16.73 (6/29) to an $11.96 close (7/24, -8.5%), losing the ~$15 base and $13 shelf on…

Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that…

AI-agent-security theme is accelerating, but AKAM's July 8 re-firing (+8–10% toward $126) has fully faded to ~$115, rolling back toward the June lows — a legacy-CDN-to-security/compute pivot that is NOT confirming the theme's momentum. The…

June fuel-relief momentum trade failed at its 2026-07-21 binary: Q2 economic fuel spiked 85% YoY to $4.43/gal (no Hormuz relief), revenue missed at $4.065B, and Q3 guided to $0.00–$1.00 adj EPS vs $1.38 est. Sell-side now cutting targets…

Door-hardware compounder gapped +12.6% on 2026-07-23 after a Q2 beat (adj EPS $2.40 vs $2.22) and an FY26 guide raise to $8.85–9.00; durable legs are the electronic-access mix shift and an emerging data-center physical-security vertical…

Ethanol-to-specialty/low-carbon pivot re-rated ~6x off $0.92, but both fuel catalysts — the June 45Z cash sale and the Russell index add — are spent, and price has round-tripped from the $6.11 July high to ~$4.64, losing the $5.10-$5.20…

Healthcare-staffing cyclical recovery, real but MATURING and now at the highs: ~$32.9 (2026-07-24), just off a fresh 52-wk high $36.27 (~+120% off $14.87). Truist's 2026-07-22 lift to a Street-high $40 Buy is the first target leading…

Cash-return re-rating in a shrinking business: EV of US$27m against US$2.67bn cash, a US$400m buyback authorised 2026-07-28 (~15% of market cap) and a restated RMB1.5bn 2026 dividend floor drove a +40% run off the 2026-06-05 low of $16.53.…

Self-help turnaround at a leveraged lab-supply distributor is being repriced: the 2026-07-29 Q2 print put VWR Distribution & Services back to +1.7% organic from -4.8% in Q1, and FY2026 organic guidance was raised to -0.5%/+0.5%. Price…

Lemonis "Everything Home" roll-up keeps closing deals — Container Store now wholly owned (2026-07-08), TwoPonds folded in (2026-07-01) — but the tape has bled from $5.83 to ~$4.96 and sits on the $4.26 52-week low as shares balloon past…

Rotation-passenger thesis is dead and the self-help turnaround hasn't ignited: BBWI made fresh relative lows near $19 into the 2026-07-12 Ulta launch, down ~42% over 12 months and below its 200-DMA while the tape holds up. Goldman cut to…

Tape flipped since early July: BBY broke to a fresh 52-week high $87.35 (~$85.41 on 2026-07-17, +27.6% YTD) on RGB-LED TV exclusivity plus an AI-PC/MacBook refresh cycle. But price sits ~8% above the $79.15 consensus target while Loop…

The premium-to-book re-rating has unwound: BH ~$384 (Jul 17) sits back under the ~$401/Class B book line while CBRL rallied to $53.61 — the holdco is falling as its main asset rises, re-widening the discount. A $500M ATM with ~$485M…

De-risking headlines (dual-primary HK listing approval, Apple Intelligence China clearance, mid-July) rallied the HK lines but the ADR kept bleeding — cap down to $37.21B (07-24) from mid-$40B in June. Structure rolled over below the $110…

The +80% Q1 turnaround re-rate round-tripped from the $6.57 high and stays broken: BLDP trades below the lost 20-EMA (~$5.00) and the $4.80 shelf in a catalyst vacuum until the 2026-08-12 Q2 print, with Susquehanna's 2026-07-10 cut to…

Busted vertical-SaaS name re-rating on cash return: the 2026-07-29 Q2 print showed +3.0% organic and an affirmed FY26 guide with upper-half commentary, against ~$850M of remaining buyback authorization and an 8.16 forward P/E. The move is…

Casual-dining margin-repair story re-rated violently on the 2026-08-05 Q2 print (adj EPS $0.39 vs $0.29, FY26 adj EPS guide lifted to $0.90–$1.00). The narrative is three days old and already gave back from $12.29 intraday to a $10.95…

Post-ASMS instrument re-rate broke back toward the $64.54 high and added a second leg: semiconductor-metrology strength (orders +20% YoY) pulled Leerink to $70 and top targets to $65–70. But at ~$62 the name sits ~13% over its 50-DMA and…

Legacy oiler U.S. Energy rebranded June 8 2026 into Big Sky Industrial, a helium + carbon-capture pivot at Montana's Kevin Dome. A five-year $285/MCF take-or-pay offtake and Q1-2026 FID anchor the story, but first cash flow is Q1 2027 and…

Both legs of the wrapper are now rolling over: WhiteFiber (WYFI, ~70.5% owned) de-rated from $38.50 to $27.57 as the June neocloud mania cooled, and BTBT slid to ~$1.50, a step above its $1.25 low. SOTP discount still ~49% (~$745.6M WYFI…

Spring miner-to-AI re-rate has fully unwound: BTDR lost the $15 shelf to $12.56 (2026-07-09) as AI-cloud ARR plateaued at ~$69M for a 2nd month. A signed-but-not-effective Tydal colocation lease (2026-06-29) and a $36M Nevada plant are the…

Casual-dining re-rate got a genuine second leg: Citi's 2026-07-10 raise to a street-high $90 (Buy) on a rewards/app traffic-inflection thesis gapped shares 7% to all-time highs (~$86, 52wk high $86.66 on 2026-07-18). For the first time the…

Q1 re-rate is spent and the tape has gone flat — CAL has chopped a tight $11–$12.6 band near $11.78 (2026-07-24), ~19% below its pre-print level and under the lost low-$13s June shelf. Slow brand-mix-shift value name, not an accelerating…

Legacy-diner turnaround has handed off from numbers to leadership: David Deno (ex-Bloomin' Brands CEO) takes over 2026-08-10 with shares roughly doubled YTD and the 2026-08-07 close of $57.79 above every published target except Argus's…

Analyst-confirmed profitability inflection (Q1'26 adj-EBITDA +$4.0M, +24% product rev) in a 25-year blood-safety grinder, but the 2.7x off the lows is largely spent and price sits near 52-week highs (~$3.00). The 2026-07-30 Q2 print is now…

Pure-play SBS paperboard cycle inflection: two announced $60/ton price increases plus ~300kt of industry capacity out YTD took Q3 adjusted EBITDA guidance to $20–30M from negative $8M in Q2. But the 2026-08-07 close of $23.31 is a 52-week…

Hormuz war-risk re-escalation fired — the US-Iran MoU collapsed and tankers were struck 2026-07-19/20 — yet CMBT stalled near $15.7, ~11% under its $17.72 high, while broad VLCC spot bled ~40% off the late-June ~$470k/day peak. The equity…

Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe.

Distressed, highly-levered beauty turnaround (net debt ~$3.17B, ~3.3-3.4x) bouncing +23% off its ~$1.82 all-time low on the ~$400M Gucci license transition to Kering and cost-out. A de-lever story, but the ~Aug-19 Q4 print is the binary…

Deal-arb thesis is now spent: the $100M Apotex asset sale closed 2026-07-01 after a 99.84% shareholder vote on 2026-06-24, so the dated binary that drove the ~3.2x off $1.85 to a $7.36 high is consumed. What remains is a cash-rich clinical…

Hardware-to-platform crossover: Q2 2026 Platform revenue $85.0M (+5%) now exceeds Products $71.3M (-22%), and shares gapped +22.9% on 2026-08-05. The fuel was non-recurring — $20.3M IEEPA tariff refunds plus a $6.4M reserve release; the…

Elliott-driven turnaround at a beaten-down CRO: a ~$295M cost program plus 120–150bps margin expansion is re-rating the stock even with organic revenue still negative (-1.5% Q1), while Q1 proposals up high-single-digits YoY hint DSA…

Turnaround re-rating still catching fresh fuel: analyst targets cluster up to $160 (BofA 2026-07-23, Seaport 2026-07-20) on North America DTC re-inflecting, lifting CROX to ~$135 within 4% of its all-time high at ~10x forward. Revenue is…

Margin-inflection leg: Q2 FY26 (2026-08-06) delivered adj EPS $0.23 vs $0.07 consensus, a record 33.2% gross margin and an FY26 EPS guide of $0.85–$0.94 vs $0.72 est. Price closed 2026-08-07 at $14.35, the 52-week high and above three of…

Legacy-networker AI re-rate intact and now at its binary: the $118–120 shelf held through July, price closed $121.43 on 2026-08-07 with RSI(14) at 78.4, and five sell-side target raises landed 07-22 → 08-06 (Citi $112→$139) ahead of the Q4…

Policy-relief leg stayed dead: the 2026-07-24 Jeffersonville HJT cell-plant opening — the reshoring narrative's first hard proof point — drew no bid, with the 2026-08-07 close at $15.91, 52.6% under the $33.58 adjusted high. The 2026-08-27…

Legacy IT-services name being re-underwritten as an enterprise-AI deployment partner: 2026-07-29 Q2 lifted FY26 adj EPS guidance to $5.70–$5.82 and expanded margin 40bps while cutting the FY revenue band to $22.04–$22.35B. The re-rating is…

Currency/payments spinoff re-rating on two legs: a US "Catalyst Series" banknote redesign (redesigned $10 late 2026, higher-denom print volume ~+90% vs 2025) plus a De La Rue + Antares authentication roll-up (SAT sales +51% YoY, FY sales…

June's $50M raise at $3.05 (16.4M sh) is already underwater: shares last $2.775 (2026-07-02), below the offering floor, with ~$50M shelf undrawn and soft Q2 guidance (rev $93–95M, adj. EBITDA still negative) into the 2026-08-10 print. A…

Fusion pivot is the leg: the 2025-12-18 all-stock TAE Technologies merger (>$6B, ~50/50 fully diluted) is what's actually being bought, while the crypto-treasury leg was terminated 2026-08-07. The S-4 was still unfiled as of 2026-08-05,…

Legacy e-signature base being re-wrapped as AI "Intelligent Agreement Management" — IAM went 10.8%→12.6% of ARR in one quarter and is guided to ~18% by 2027-01-31, but total growth is still ~9%. Price has recovered to roughly the consensus…

The pivot is now structural: the rail subsidiary was sold 2026-08-05 (related party — interim CFO owns 50% of the buyer), leaving an edge-colocation operator carrying a 2026-07-16 five-year 10 MW hyperscaler contract worth >$111M. The tape…

Census-recovery re-rate broke at the 2026-08-04 Q2 print: EPS beat ($4.02 vs $3.88) but FY26 EPS was only affirmed at a $14.65 midpoint vs $14.82 consensus, with H2 revenue-per-treatment guided slightly negative. Price -23.7% from the…

Legacy IT-services decliner being re-rated as an AI-centric pivot: AI-framed leadership change 2026-07-30, ElevenLabs and Primary partnerships inside ten days, FY27 non-GAAP EPS guide of $2.40–$2.90 affirmed against a $10.84 close.…

Legacy IT-services base re-rating on an AI-delivery pivot: the 2026-07-29 Q2 beat (adj EPS $0.91 vs $0.82) plus a $115M Army DEVCOM AI award drove +16.3% on 2026-07-30. Revenue is still -1.3% YoY, RSI(14) hit 94.5 at the 2026-08-07 close…

Post-collapse deleveraging read: Q3 FY26 (2026-08-07) beat at $271.7M revenue and $0.56 adj EPS vs $0.27, and the FY26 adj EPS guide went to $1.80–$1.90 — three months after a 57.8% one-day break on 2026-05-05. The leg being bought is a…

Post-Colfax orthopedic pure-play turnaround: LimaCorporate integration plus FCF-conversion recovery (43% in 2024 toward a 70–80% target) is the self-help story, but price has rolled over from $34 toward $27 while three brokers cut targets.…

IQ SST AI-data-center pivot (announced 2026-04-28) that drove a spring squeeze has stalled — stock de-rated ~16% in a month to ~$45 (2026-07-09), sell-side uniformly neutral with PTs on top of price (Susquehanna $45, 2026-07-10), and SST…

AI-native revenue is compounding ($160M in Q2, >11% of total) but the task-based book is running off faster — FY26 organic constant-currency growth was cut to 2.0%–3.0% on 2026-08-06, Q3 guided to ~1.7% YoY, and the stock closed $97.43,…

Smadex AI-DSP re-rate broke to a new 52-week high of $13.48 with no dated company news since 2026-07-12 — an anticipatory leg into the 2026-08-10 Q2 print, the binary on whether Q1's +204% ATS growth and ~22% EBIT margin held.…

Legacy expense-SaaS pivot re-rated on the 2026-08-06 Q2 print: revenue $33.9M beat $33.688M, paid-member decline halved to -2% YoY, FY26 FCF guide doubled to $12M-$14M, ~7% of shares retired, and New Expensify ARR from net-new customers…

Legacy campus-networking name re-rating ~+140% off Feb lows on the Platform ONE / Agent ONE AI-NetOps story plus SaaS ARR +29% YoY; theme still ACCELERATING but spot ($33.71, 07-10) has run through consensus PT $29.06 into the June bull…

Activist-plus-new-CEO turnaround has stopped accelerating and started digesting: after the +30% run off Garden's $40.6 buy, price has chopped $50–54 for three weeks while sell-side targets climbed past spot (Goldman $61 on 7/10, Barclays…

Legacy-CCaaS AI pivot staged a sharp V-recovery: +29% off the $19.70 June swing low to $25.42, reclaiming the broken $22 shelf on a 2026-06-23 next-gen Voice AI Agents launch and an AI-first leadership overhaul. Now pressing the $26.26…

AI-manufacturing re-acceleration: the 2026-07-09 Cerebras CS-3 production expansion is the first company-specific bid since the S&P-inclusion +6% pop round-tripped to ~$147, refreshing the data-center power/EMS narrative into the ~07-29 Q1…

Legacy watch/accessories brand whose margin-first turnaround is showing in the numbers: Q1 2026 swung to $12.0M operating income from a $(6.7)M loss on net sales of $224.8M, and the FY2026 guide (-4% to -6% sales, 3-5% adjusted operating…

Agentic-operations pivot is compounding in the segment data — Advanced Technology Solutions +24.1% to $363M, FY guide raised to at least 25% on 2026-08-06 — but the 73% legacy book grew 1.9% and caps total growth near 7%. Shares fell ~3%…

June drawdown fully retraced — $23.01 close (2026-06-22) to $27.63 (2026-07-29), still short of the $27.76 shelf from 2026-06-01 — and it happened on no company news. The now-confirmed 2026-08-06 Q1 FY27 print is the first quarter with…

Legacy B2B data business attempting to re-rate as an AI go-to-market platform. Q2 (2026-08-05) beat and raised on 1.2% revenue growth, 89% NRR and a $650.5M goodwill impairment; the stock ran ~14% in two sessions to $4.18 (RSI 76.9), above…

Turbo cash-cow re-rated (~8–9x → ~18x) on a datacenter/industrial oil-free cooling narrative; the parabolic Feb→June leg (~$20→$36) is spent, shares faded ~11% to the 50-day near $32.30, and the ~late-July Q2 print is the first chance to…

The July stall resolved upward: HAE broke its $77–80 July range to close $85.54 on 2026-07-31, 2% under the 52-week high, on a BofA target raise to $93 citing peer multiples rather than new data. The 2026-08-06 Q1 FY2027 print is three…

The 2026-07-08 double beat was sold — closed $25.18, -10.2% — because margins compressed (GM 46.0%, -110bp; adj EPS $0.17 vs $0.41). The live leg is now deleveraging: net leverage 3.48x from 3.87x, debt $716.1M from $871.0M, FY27 FCF…

BTC-miner→AI-compute re-rating has its first blue-chip proof — BUZZ HPC's $220M Bell/Cohere sovereign-AI GPU deal (~$70M ARR) on top of $35M contracted ARR — but the stock stalled ~$3.79 below its early-June highs as BTC bled ~45-50% off…

Transformational Steelcase merger made HNI the #1 North American office-furniture maker at ~$5.8B revenue, but the tape is dead near $40 versus ~$70 analyst targets — a show-me integration grind, not an accelerating narrative. The…

Margin re-rate, three days old: Q2 gross margin 48.4% (+800bps) and a four-way FY2026 guidance raise on 2026-08-05 drove a ~39% single-session repricing. Price at $5.46 is a 52-week high, RSI 83.3, and above both $5 targets raised in…

Freight-cycle recovery has a stronger structural leg than the rate data alone implied — regulatory driver purge (~194k CDLs, ELP enforcement) plus spot above contract for the first time since 2021. But HTLD is unprofitable, all six…

No base, no scheduled company event before UNBOUND on 2026-09-16.

Med-device turnaround re-rating is now fully banked into Hold-grade targets: BMO initiated Market Perform $19 (Jul 9) and Citi raised to Neutral $19 (Jul 8), both landing on the tape (~$18.76). The distressed-to-fair leg is done; only…

Post-sanctions PACE turnaround still delivering (FY2026 adj-EBITDA guide $85–90M, census ~8,050 +6.9% YoY), but the tape shifted: a $12.11 52-wk high failed back into range ($11.18 close 2026-08-07), and the 2026-07-31 S-3 registered…

Long-form streaming growth is broken in the reported numbers — Q1 2026 revenue -13% YoY and operating income flipped to a RMB228.4m loss — so what is left to buy is the micro-drama/overseas/AI-cost pivot, which has no disclosed revenue…

Section 232 aluminum supply-shock (50% duty through 2027) plus a Q1 earnings inflection already repriced KALU ~+175% YoY to a $195 high; the move is MATURING toward SATURATED with price at/above every published target. The estimated…

Former Bitfarms miner→AI/HPC-datacenter pivot has rolled over: June's push to ~$6.14 into Citizens' $10 initiation retraced to a ~$4.975 ref by 07-06, losing the $5.00 convert shelf and drifting toward the $4.00–4.20 base. Still zero…

Deep-value staffing name three years into a specialty-vertical pivot (Europe sold to Gi Group, Motion Recruitment bought), but the tape is dead and the theme engine keeps re-labeling it with no anchoring headline — nothing is accelerating…

Cyclical staffing recovery is fully printed — Q1 returned to YoY growth, Q2 guided +~4% — but price ran ~24% in three weeks to a fresh all-time high near $58.6, ~38% above the $42.33 consensus PT, into the confirmed 2026-07-27 Q2 print. A…

Distressed post-IPO childcare name has retraced ~180% off its $1.75 spring low to $4.93 as growth shifts to B2B/employer care and before-after-school (Champions +17% YoY), while the core ECE business still shrinks (−3% enrollment). The ~13…

Pension-reversion fat pitch fired and is spent; the re-rate has fully unwound from the $14.87 May high to ~$7.78, losing the $9 June shelf and printing a $4.94 52-week low. A July 1 resale shelf of up to ~39.46M shares and a June 29 Sell…

Legacy-risk-transfer re-rating: the 2026-07-30 Talcott deal cedes ~$5.8B of GUL statutory reserves for ~$200M all-in statutory capital, alongside a Q2 adjusted EPS beat at $2.24 vs $1.96. But the information is out, price sits 2.1% under…

AI-reset narrative — a busted online legal-forms IPO repositioning as an AI-enabled SMB subscription platform (Anthropic partner, AI "digital mailroom") — drove a +29% 30-day rip into July. But it's stretched into the 2026-08-05 Q2 print,…

Morgan Stanley broke the all-Hold wall on 2026-07-06, resuming at Overweight with a $30 target and a $3 EPS-power call vs ~$2 consensus — the first real upgrade catalyst since the Q1 beat. But price faded the note ($23.99 → $22.64 by…

AI/HPC power-buildout re-rate is the leg being bought — the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8 GW — but the golden-cross base fully round-tripped to ~$11.4 as analysts cut across the board…

Post-divestiture Mativ is being repriced as a self-help deleveraging story: the 2026-08-05 Q2 print delivered record adj EBITDA of $75.0M at a 14.1% margin and cut net leverage to 3.8x on $60.4M of free cash flow, and shares gapped +9.2%.…

AI-data-center re-rating leg is unwinding — round-tripped from the $105.91 May ATH to the ~$84 50-day EMA under an unrebutted J Capital short thesis and a 2026-07-13 TD Cowen PT cut to $90; only the cyclical MCU/industrial recovery (~93%…

Cheap cyclical furniture reset that squeezed ~24% off its 2026-06-24 post-earnings low then STALLED flat ~$21.5 for three weeks under the $23.18 52-week high. Narrative is decelerating (Q4 orders -6.3%, backlog -10.8%), leadership is…

Medicaid-margin-trough recovery, now fully re-rated: June's Illinois-win + BofA-double-upgrade breakout to ~$230 has matured into target catch-up (July raises to $230-250, but ratings stayed neutral and Barclays cut to $184). The whole leg…

Margin-led re-rate (Q1 FY27 GM 57.3%, +320bp; adj EPS $0.32 vs $0.08 est) is already priced at $38.65, ~3% off the $39.85 high after six weeks of chop. The live variable is the 2026-07-24 Section 122 expiry: the 10% Swiss-watch surcharge…

Post-COVID survivor re-rate has run its momentum leg and is now digesting a parabolic +31% push to a fresh 52-week high of $6.22 (June 26). Every driving catalyst is public, the move is idiosyncratic with no life-science-tools cluster…

Legacy plastics maker re-rated ~2.4x on a "Focused Transformation" — MTS distribution arm in discontinued ops, capital concentrated behind Signature/MegaDeck composite matting (Infrastructure orders +130% YoY, Q1 adj EPS $0.44 vs $0.28).…

Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and Precise MRD colorectal/renal was pulled forward to Q3. Structure has repaired but now…

SolarWinds-spinoff MSP software vendor pivoting to cybersecurity via Adlumin MDR (26.7% of rev, +17.5% YoY); the cyber/MDR theme is accelerating but NABL's own tape is broken — ~40% off, ~$4.77 near the $2.92 base low after a soft Q2…

Oncology-dx turnaround ACCELERATING — NGS +26%, PTEN IHC CDx (first FDA IHC companion dx in prostate, paired to AZ's TRUQAP) launched Jul 9, and TD Cowen $14→$19 / BofA $11→$16 on Jul 13 lifted consensus to ~$15.67, back above spot. But Q2…

Cyclical zinc-recovery confirmed and fully priced: Q1 EBITDA +126% YoY and Aripuanã's record 13kt ramp drove a run to the $16.89 high, but the equity now chops $12–13 while LME zinc printed a fresh 2026 high near US$3,622 — a bearish…

The IPO re-rate leg already failed — price sits 36.7% under the $18.45 52-week high. What is left is a margin/deleveraging story: Q1 adjusted EBITDA margin 21.0% against a 23.5–23.8% FY26 guide, funded by $70–80M of restructuring savings.…

Post-capitulation base off the $41.35 low is holding, but the estimate-revision direction has not turned. The 2026-07-22 decision to sever China distribution (Topsports online terminated 2027-01-01) deepens the near-term China reset even…

AI-networking legacy re-rate extending on a harder catalyst leg — first commercial AI-RAN platform with Nvidia (07-15) plus Taiwan Mobile, Orange Belgium and NestAI defense wins. Theme ACCELERATING, but the 2026-07-23 pre-open Q2 print is…

Genuine VAR margin-mix turnaround (Q1 GM +240bps, cloud GP +35%) but a derivative AI tag: hardware GP guided flat, sales +1%. Range-bound $102–123 since the early-June rejection; ~$110 already sits above the ~$103 street target with a…

Post-crash PEO turnaround: margin repair plus the Feb-2026 Workday HRScale launch drove a ~160% bounce off the $18.57 low, but worksite employees are still contracting (303k, -1% YoY) and the 2026-07-29 Q2 print is a hard binary. No…

Mid-July analyst cluster — JPM & Barclays Overweight PT $7, UBS Neutral PT $4.75 — has sell-side validating the Chris Peterson turnaround, and the tape pushed higher into 7/22. But a binary Q2 print lands before open 7/31, gating a full…

Legacy steel-pipe maker re-rated into a water-infrastructure + precast roll-up on a record $373M WTS backlog, an ~83% Q1 beat, and the Permalok RBJ field win. Narrative intact but the setup is extended — last near $148, ~35% above the…

Reimbursement-reversal re-rate has already been spent: CMS restored pre-May-18 bone-growth-stimulator rates (reported 2026-07-02) and the 2026-08-05 Q2 print beat on both lines with FY26 guidance raised to $845–855M / $95–98M adj EBITDA —…

FY27 guided as a reinvestment year: revenue $5.135–5.185B versus FY26 actual $5.246B, adj EBITDA margin 32–33% versus 36.3%, funding $100–200M of growth spend. The AI-data-foundation re-rating has not arrived; what remains is $807.5M FY26…

Oatly doubled its FY2026 constant-currency revenue growth guide to 8–10% from 3–5% on 2026-07-22 and printed positive adjusted EBITDA (+$0.4M). The re-rating leg is roughly two weeks old, RSI is 71, and no company catalyst is scheduled…

Automation-and-buyback operating-leverage story re-rating a de-rated HCM name: Q2 (2026-08-05) beat revenue $531.2M vs $513.1M and EPS $2.78 vs $2.38, FY26 guide lifted to $2.197–2.212B, nine targets raised 2026-08-06. Leg is fresh, but…

PBI broke the $17.62 shelf to a fresh 52-week high $18.62 (Jul 16) — the buyback/cost-cut re-rate is now extending, not consolidating. But revenue still shrinks ~3% YoY, consensus PT $16.43 sits below spot, and Q2 prints after close Jul…

Recovery leg re-fired: $66.06 (2026-06-05) → $71.49 on 2026-07-15 (+5.9%) → $73.20, back within 3% of the $75.25 high and ~6% ABOVE the $68.80 consensus target. Wells Fargo's 2026-07-10 note flags June financing data accelerating into a Q2…

Rig-reactivation cyclical is basing, not broken: June averaged 95 US rigs (vs ~90 Q2 guide), the July EIA STEO lifted 2026 Henry Hub to $3.67, gas rigs turned up 122→126, and Piper upgraded to Overweight 07-14. Price bottomed $8.57 (07-01)…

Ad-tech SSP growth-inflection re-rating: Q2 2026 revenue $78.6M, +11% YoY, first double-digit quarter after three declines, with a Q3 guide of $75–77M vs $71.1M consensus. The 2026-08-06 print repriced the stock to a 52-week high $17.78…

Post-print wreckage, not a turn. FY26 EPS held only via a ~$100M one-time tariff refund while the revenue guide went flat (2026-06-03, −25% overnight); BofA capitulated to Underperform/$70 on ~50% EMEA exposure (2026-06-25). The bounce to…

Luxury-resale turnaround has reached a durable adjusted-EBITDA inflection — FY2025 positive EBITDA all four quarters, Q1 2026 GMV +24%, FY guide raised — but the re-rate off ~$5 is largely spent and the tape is range-bound near $11.4. The…

White-collar staffing in secular decline: Q2 EPS collapsed to $0.26 (2026-07-23) as AI automation and a frozen hiring market gut permanent-placement demand. The >5% dividend yield reads as a value-trap signal rather than a floor. No…

Beaten-down UCaaS name popped ~24% on a 2026-07-23 Q2 beat-and-raise plus an OpenAI-adoption headline. But sell-side stayed Neutral (PTs $40–43), and the AI pivot is thin — internal adoption plus a hackathon, no attached revenue. Buying a…

The sell-the-news break is now confirmed: RUM lost the $6.46–$6.66 100/200-day shelf and closed $5.76 on 2026-07-17, -19% from the post-rebrand tape and within 25% of the $4.62 52-week low. Every moving average is overhead. The 2026-08-10…

June's +20% deleveraging bounce has fully round-tripped: $1.99 (6/26) back to $1.73 (7/17), now under the 50-day near $1.79 after failing exactly at the $1.99 consensus PT. Balance sheet is fixed, narrative is not accelerating, and a…

GPU-normalization narrative broke at the 2026-07-30 print: revenue and adjusted EPS beat consensus, but adjusted EPS fell 17% YoY, franchised segment income −23%, and EchoPark FY26 GPU guidance was cut ~$300 at the midpoint. Shares…

Legacy-EMS AI re-rate (AMD/ZT Systems datacenter manufacturing) blew off to a $282.72 ATH then corrected ~16% off the highs; the est. ~2026-07-27 FQ3 print is now ~9 days out and is the binary — it tests whether FQ2's +102% YoY surge was…

The ETH-treasury flywheel is inverted: mNAV 0.81x (The Block, 2026-08-08) means any share issuance dilutes ETH-per-share, so the only live legs are buyback-driven discount closure and a new fee business (Galaxy SharpLink Onchain Yield…

Online-styling turnaround printed a 5th straight growth quarter and first sequential client gain (Q3, 2026-06-10) with a raised FY guide, but the post-print pop has fully round-tripped to ~$3.58 (2026-07-24) onto the $3.50 shelf, a second…

Tariff-recovery leg has stalled into a $39.71–$47.11 range with insiders selling every rally and zero buys; the whole story now hinges on the confirmed 2026-07-30 Q2 print. Consensus targets sit at or below spot ($43.75, 07-16), adjusted…

Korea AI-infra narrative is loud while the ADR bleeds: $46.00 (06-02) to $30.62 (07-17), and both the 15GW plan (07-05) and JPMorgan's Overweight upgrade (~07-16) failed to hold a bid. The story flipped from AIDC margin accretion to ₩140T…

Legacy web-analytics SaaS (IPO $22, now ~$7) repositioning as an LLM-data supplier: a seven-digit AI training-data contract (disclosed 2026-05-18) plus AI Agents launch is the re-rating story. But Q1 2026 growth decelerated to +10% YoY and…

AR-pivot narrative is broken and sells on every catalyst; five desks compressed targets to a $5 wall (UBS, Mizuho, Wells, DA Davidson $5; Goldman $6) into a hardening child-safety litigation wall. A legacy-pivot restructuring without a…

The split-momentum leg is dead. SNEX round-tripped from a $139.01 all-time-high close (2026-06-18) to $102.99 on 2026-07-17 — down 12.5% in a week, 22.4% in a month — while insiders dumped $94.2M over three months with zero buys.…

June's busted-IPO recovery leg has fully reversed. D.C.'s RESALE Act (10% resale-markup cap, effective 2027-01-01) plus a Texas AG probe into undelivered World Cup tickets broke the experience-economy narrative; at ~$8.60 STUB trades below…

Coal-policy sympathy trade is fully dead: SXC has gone nowhere for three weeks, $8.39 on 2026-06-27 to $8.37 on 2026-07-17, pinned to the $8 shelf with no narrative velocity. The only live variable is the Q2 print, pulled forward to…

Mix-shift re-rating: AI Services hit $66.1M (+25.8%) in Q2 CY2026 on 2026-08-05 — seventh straight quarter above 25% — and is guided above 30% YoY in Q4 on AV/robotics work, against a 25%-of-revenue Trust & Safety book the market assumes…

Deep-cyclical industrial staffer re-rated +140% off the $3.18 low on a staffing-demand recovery and a data-center/energy labor boom lifting PeopleReady +19% YoY. Still loss-making (Q1 net -$19.8M), margins compressed, and the…

Fallen-angel telehealth turnaround re-rating off lows: TDOC doubled from its $4.40 low to a fresh $9.78 52-week high on the Walmart Better Care distribution deal and BetterHelp's shift to insurance-reimbursed visits. But total revenue…

The AI-datacenter-landlord re-rate has stalled: TH peaked at $20.85 and has given back ~21% to $16.36 (2026-07-17) as TDR Capital affiliates distribute shares in-kind to partners, losing the $17 secondary clearing shelf while Oppenheimer…

Beaten-down insulin-pump turnaround; the whole re-rate hinges on the tubeless Mobi ("Toby") 510(k) — planned for a Q2 filing but still unconfirmed after the quarter closed 2026-06-30 — plus margins scaling toward a ~60% Q4 exit. Shares…

Debt refi (2026-07-09: $86M Deerfield convert → $75M OrbiMed term loan to 2031, no equity) removed the 2027 maturity wall and triggered a sell-side cluster — Lake Street initiate $10 (7/06), BTIG $8→$9 (7/09), consensus $8.40. But a 24x…

Legacy GEO operator re-rating on a funded LEO pivot: 2026-08-04 C$2.3B, 15-year Canadian Arctic Mil-Ka contract expands Lightspeed 156→225 satellites and lifts the 2032 revenue target to US$4.9B from US$3.2B. Price closed at the 52-week…

Hyperscaler dark-fiber demand turned the post-Windstream deleveraging grind into a growth story (~$1.5B disclosed funnel, $68.7M of Q1 IRU revenue from one hyperscaler), but the June re-rate to ~$11 has stalled in a three-week range above…

New-management turnaround re-rating has stalled: after Goldman's June double-upgrade drove VAC to a $105.97 high, price rolled ~11% to the low-$90s while the two most recent Street notes (Morgan Stanley $52, Wells Fargo $68) are both…

Legacy-pivot re-rating resumed: price cleared the post-pivot high-teens shelf to close $23.67 on 2026-08-07 (+39.7% 3m, RSI 79.3) with no company headline since the 2026-06-08 dual China approvals. Story is known and still working, but the…

Q1 blowoff (+47% on 2026-06-02, adj EPS $0.60 vs $0.32) already re-rated the equity to a $88.57 high before fading to the mid-$70s. Activist overhang cleared, sell-side no longer leading price, no dated catalyst until the ~late-Aug Q2…

Margin-inflection turnaround has stalled: after the June Evercore-driven pop, W has faded ~10% back to the ~$84–85 recovery base ahead of the binary Aug 4 Q2 print. Wedbush's Jul 16 Neutral/$104 initiation and a ~$100-capped consensus mark…

Tariff-moat re-rating on preliminary 82–129% duties vs Chinese trailers has matured: a $130M 4.00% convertible priced 2026-07-16 turned the balance-sheet watch into a dilutive raise, and a binary loss-making Q2 print lands 2026-07-29…

shares gapped ~29% to a 52-week high. The next confirming datapoint is not until the ~late-October Q3 update.

Post-print relief gap: the 2026-07-24 Q1 beat on adjusted EPS ($2.12 vs ~$0.58) plus improving year-over-year delinquencies drove a +15% pop back to ~$208, but revenue missed ($139.2M vs $143.9M) and GAAP EPS was just $1.33. A low-float…

Beaten-down dental franchise mid-turnaround: new CEO killed the dividend to cut debt and buy back stock, but Q1 revenue was dead flat and operating margin swung negative — no accelerating narrative, a Hold-rated value trap into the…

Distressed-deleveraging special situation that round-tripped its June activist pop into a binary 2026-07-30 Q2 print. At ~$2.60 it sits below the $2.75 Hold consensus and inside the $2.25–$2.50 target band; anchor buyer STARTEEPO (8.8M sh,…

Delisting binary fully resolved to the survive side — Nasdaq confirmed regained compliance 2026-07-20, but with a one-year no-cure monitor attached. What's left is a ~$7M psilocybin micro-cap with a going-concern warning and heavy…

Post-gap recovery has extended to $5.73 (2026-08-07), +42.5% in three months, into the $6–$7 band where support broke — on no new fundamental datapoint since the 2026-06-02 Q1 FY2027 print. The answer-engine repositioning is still absent…